Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BioAlliance appoints Pierre Morgon chief operating officer

This article was originally published in Scrip

Executive Summary

BioAlliance Pharma (France), a speciality pharmaceutical company focused on the treatment of infections in cancer and HIV, has strengthened its management board with the appointment of Pierre Morgon as chief operating officer. He joins from Schering-Plough France, where he managed primary care operations in France for two years and the partnership with MSD. From 2004 to 2006, Mr Morgon was vice-president of hospital operations at Bristol-Myers Squibb, and from 2003 to 2004 he served as general manager of Yamanouchi Pharma France.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts